tiprankstipranks
Trending News
More News >
CorMedix raises Q2 net sales view $35M-$40M from $31M, consensus $30M
PremiumThe FlyCorMedix raises Q2 net sales view $35M-$40M from $31M, consensus $30M
11h ago
CorMedix price target raised to $17 from $13 at RBC Capital
Premium
The Fly
CorMedix price target raised to $17 from $13 at RBC Capital
4d ago
Elliott buys Equinix, exits NRG in Q1
Premium
The Fly
Elliott buys Equinix, exits NRG in Q1
1M ago
Cormedix’s Strong Sales Growth and Promising Future Prospects Justify Buy Rating and Increased Price Target
PremiumRatingsCormedix’s Strong Sales Growth and Promising Future Prospects Justify Buy Rating and Increased Price Target
2M ago
Cormedix’s Promising Financial Outlook and Strategic Positioning Support Buy Rating
Premium
Ratings
Cormedix’s Promising Financial Outlook and Strategic Positioning Support Buy Rating
2M ago
CorMedix price target raised to $20 from $17 at Truist
Premium
The Fly
CorMedix price target raised to $20 from $17 at Truist
2M ago
Positive Outlook and Strong Market Demand Justify Buy Rating for CorMedix
PremiumRatingsPositive Outlook and Strong Market Demand Justify Buy Rating for CorMedix
2M ago
Cormedix’s Promising Growth Trajectory and Strategic Initiatives Support Buy Rating
Premium
Ratings
Cormedix’s Promising Growth Trajectory and Strategic Initiatives Support Buy Rating
3M ago
CorMedix’s Strong DefenCath Performance and Growth Prospects Justify Buy Rating
Premium
Ratings
CorMedix’s Strong DefenCath Performance and Growth Prospects Justify Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100